Clinical Trials Browser

Enrolling by invitation × Breast Neoplasms × Cyclophosphamide × Clear all

NCT03328026 2025-02-04

Combination Study of SV-BR-1-GM With Retifanlimab

Phase 1/2 Enrolling by invitation

Breast Neoplasms